BiotechTube
Home/Mapi Pharma/Nadav Bleich Kimelman, DMD, Ph.D.
NB

Nadav Bleich Kimelman, DMD, Ph.D.

VP Pharmaceutical Development

Mapi Pharma

Therapeutic Areas

NeurologyPainEpilepsyPsychiatry

Mapi Pharma Pipeline

DrugIndicationPhase
Glatiramer Acetate DepotRelapsing‑remitting Multiple SclerosisPhase 3
Pregabalin ERNeuropathic Pain / EpilepsyPreclinical
GLP‑1 Peptide Long‑Acting InjectableMetabolic DiseasePreclinical
Buspirone ERAnxietyPreclinical
Paliperidone DepotSchizophreniaPreclinical
Aripiprazole DepotSchizophreniaPreclinical

Leadership Team at Mapi Pharma

EM
Ehud Marom
Chairman & CEO
UD
Uri Danon
Executive VP
IZ
Irit Zalayet
VP Finance
SR
Shai Rubnov, Ph.D.
VP R&D
AM
Alex Mogle
VP Corporate Development
LP
Laura Popper, M.D.
VP Clinical Development
OM
Oren Milani
Head of Quality
View full Mapi Pharma profile